Citadel Advisors - EVOKE PHARMA INC ownership

EVOKE PHARMA INC's ticker is EVOK and the CUSIP is 30049G104. A total of 27 filers reported holding EVOKE PHARMA INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of EVOKE PHARMA INC
ValueSharesWeighting
Q4 2021$26,000
-50.0%
45,892
+15.4%
0.00%
Q3 2021$52,000
-63.6%
39,769
-61.6%
0.00%
Q2 2021$143,000
+30.0%
103,529
+72.0%
0.00%
Q1 2021$110,000
-47.6%
60,200
-26.1%
0.00%
Q4 2020$210,000
-71.0%
81,500
-47.2%
0.00%
Q3 2020$725,000
+2238.7%
154,427
+480.5%
0.00%
Q1 2020$31,000
-16.2%
26,602
-54.9%
0.00%
Q2 2019$37,000
+42.3%
59,047
+404.4%
0.00%
Q4 2017$26,000
-23.5%
11,706
-30.1%
0.00%
Q4 2016$34,00016,7510.00%
Other shareholders
EVOKE PHARMA INC shareholders Q4 2017
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 175,000$448,0000.59%
SPHERA FUNDS MANAGEMENT LTD. 500,000$1,280,0000.22%
PRECEPT MANAGEMENT LLC 95,000$243,0000.15%
Family Management Corp 10,425$27,0000.02%
STATE OF MICHIGAN RETIREMENT SYSTEM 400,000$1,024,0000.01%
Acrospire Investment Management LLC 2,489$6,0000.01%
A.R.T. Advisors, LLC 15,413$39,0000.00%
NORTHERN TRUST CORP 29,214$75,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 23,048$59,0000.00%
DEUTSCHE BANK AG\ 200$00.00%
View complete list of EVOKE PHARMA INC shareholders